Literature DB >> 9419166

Induction of Th2 cytokine expression for p27-specific IgA B cell responses after targeted lymph node immunization with simian immunodeficiency virus antigens in rhesus macaques.

S Kawabata1, C J Miller, T Lehner, K Fujihashi, M Kubota, J R McGhee, K Imaoka, T Hiroi, H Kiyono.   

Abstract

To determine if there is an association between the isotype of simian immunodeficiency virus (SIV)-specific B cell responses and the profile of Th1 and Th2 cytokine expression, rhesus macaques were immunized with SIV antigens via the iliac lymph nodes, using a targeted lymph node (TLN) immunization procedure. When CD4+ T cells purified from antigen-stimulated peripheral blood mononuclear cells were analyzed, the levels of Th2 cytokine production were gradually increased after the second and third immunizations. However, interferon-gamma production did not change. Analysis of SIV-specific B cell responses revealed that the main isotype was IgG after the second and third immunizations. In addition, a peak of SIV-specific IgA B cell responses was noted following the third immunization. These findings suggest that the induction of Th2 type responses in TLN-immunized rhesus macaques reflects the sequence of initial induction of SIV-specific IgG-producing cells followed by IgA-secreting cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9419166     DOI: 10.1086/513811

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  10 in total

1.  Targeted salivary gland immunization with plasmid DNA elicits specific salivary immunoglobulin A and G antibodies and serum immunoglobulin G antibodies in mice.

Authors:  S Kawabata; Y Terao; T Fujiwara; I Nakagawa; S Hamada
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

Review 2.  Mucosal immunity: overcoming the barrier for induction of proximal responses.

Authors:  Brent S McKenzie; Jamie L Brady; Andrew M Lew
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

3.  Mucosal and systemic adjuvant activity of alphavirus replicon particles.

Authors:  Joseph M Thompson; Alan C Whitmore; Jennifer L Konopka; Martha L Collier; Erin M B Richmond; Nancy L Davis; Herman F Staats; Robert E Johnston
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-27       Impact factor: 11.205

4.  Effects of the nature of adjuvant and site of parenteral immunization on the serum and mucosal immune responses induced by a nasal boost with a vaccine alone.

Authors:  B Guy; S Fourage; C Hessler; V Sanchez; M J Millet
Journal:  Clin Diagn Lab Immunol       Date:  1998-09

5.  Targeted lymph-node immunization with whole inactivated simian immunodeficiency virus (SIV) or envelope and core subunit antigen vaccines does not reliably protect rhesus macaques from vaginal challenge with SIVmac251.

Authors:  X Lü; H Kiyono; D Lu; S Kawabata; J Torten; S Srinivasan; P J Dailey; J R McGhee; T Lehner; C J Miller
Journal:  AIDS       Date:  1998-01-01       Impact factor: 4.177

6.  Systemic and mucosal immunizations with fibronectin-binding protein FBP54 induce protective immune responses against Streptococcus pyogenes challenge in mice.

Authors:  S Kawabata; E Kunitomo; Y Terao; I Nakagawa; K Kikuchi; K Totsuka ; S Hamada
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

7.  Immunoglobulin G, plasma cells, and lymphocytes in the murine vagina after vaginal or parenteral immunization with attenuated herpes simplex virus type 2.

Authors:  E L Parr; M B Parr
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

Review 8.  New routes for allergen immunotherapy.

Authors:  Pål Johansen; Seraina von Moos; Deepa Mohanan; Thomas M Kündig; Gabriela Senti
Journal:  Hum Vaccin Immunother       Date:  2012-10-01       Impact factor: 3.452

9.  Nonmucosal alphavirus vaccination stimulates a mucosal inductive environment in the peripheral draining lymph node.

Authors:  Joseph M Thompson; Michael G Nicholson; Alan C Whitmore; Melodie Zamora; Ande West; Akiko Iwasaki; Herman F Staats; Robert E Johnston
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

10.  Intralymphatic immunotherapy.

Authors:  Gabriela Senti; Thomas M Kündig
Journal:  World Allergy Organ J       Date:  2015-03-07       Impact factor: 4.084

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.